JP2022526855A5 - - Google Patents

Info

Publication number
JP2022526855A5
JP2022526855A5 JP2021560632A JP2021560632A JP2022526855A5 JP 2022526855 A5 JP2022526855 A5 JP 2022526855A5 JP 2021560632 A JP2021560632 A JP 2021560632A JP 2021560632 A JP2021560632 A JP 2021560632A JP 2022526855 A5 JP2022526855 A5 JP 2022526855A5
Authority
JP
Japan
Prior art keywords
bone marrow
composition according
msc secretome
derived msc
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526855A (ja
JP7763664B2 (ja
Filing date
Publication date
Priority claimed from US16/785,463 external-priority patent/US10881693B2/en
Application filed filed Critical
Publication of JP2022526855A publication Critical patent/JP2022526855A/ja
Publication of JP2022526855A5 publication Critical patent/JP2022526855A5/ja
Priority to JP2025083941A priority Critical patent/JP2025134698A/ja
Application granted granted Critical
Publication of JP7763664B2 publication Critical patent/JP7763664B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560632A 2019-04-09 2020-04-07 間葉系幹細胞由来のセクレトームを作製および使用するためのプロセス Active JP7763664B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025083941A JP2025134698A (ja) 2019-04-09 2025-05-20 間葉系幹細胞由来のセクレトームを作製および使用するためのプロセス

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962831371P 2019-04-09 2019-04-09
US62/831,371 2019-04-09
US201962929035P 2019-10-31 2019-10-31
US62/929,035 2019-10-31
US16/785,463 2020-02-07
US16/785,470 2020-02-07
US16/785,463 US10881693B2 (en) 2019-04-09 2020-02-07 Processes for making and using a mesenchymal stem cell derived secretome
US16/785,470 US10758571B1 (en) 2019-04-09 2020-02-07 Processes for making and using a mesenchymal stem cell derived secretome
PCT/US2020/027093 WO2020210248A1 (en) 2019-04-09 2020-04-07 Processes for making and using a mesenchymal stem cell derived secretome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025083941A Division JP2025134698A (ja) 2019-04-09 2025-05-20 間葉系幹細胞由来のセクレトームを作製および使用するためのプロセス

Publications (3)

Publication Number Publication Date
JP2022526855A JP2022526855A (ja) 2022-05-26
JP2022526855A5 true JP2022526855A5 (enExample) 2023-07-12
JP7763664B2 JP7763664B2 (ja) 2025-11-04

Family

ID=72241604

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021560632A Active JP7763664B2 (ja) 2019-04-09 2020-04-07 間葉系幹細胞由来のセクレトームを作製および使用するためのプロセス
JP2025083941A Pending JP2025134698A (ja) 2019-04-09 2025-05-20 間葉系幹細胞由来のセクレトームを作製および使用するためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025083941A Pending JP2025134698A (ja) 2019-04-09 2025-05-20 間葉系幹細胞由来のセクレトームを作製および使用するためのプロセス

Country Status (11)

Country Link
US (5) US10881693B2 (enExample)
EP (1) EP3952892A4 (enExample)
JP (2) JP7763664B2 (enExample)
KR (2) KR20220047210A (enExample)
CN (1) CN114269359A (enExample)
AU (1) AU2020270892A1 (enExample)
BR (1) BR112021020450A2 (enExample)
CA (1) CA3136614A1 (enExample)
CL (1) CL2021002655A1 (enExample)
MX (1) MX2021012461A (enExample)
WO (1) WO2020210248A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3801028A4 (en) 2018-05-30 2022-04-13 Direct Biologics LLC A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
EP3920946A4 (en) 2019-02-07 2022-11-09 Direct Biologics LLC METHOD FOR TREATING OSTEOARTHRITIS USING A COMBINATION OF EXOSOMES OF MESENCHYMATE STEM CELLS, SYNOVIAL MESENCHYMATE STEM CELLS AND SCAFFOLDS
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
IT201900022029A1 (it) * 2019-11-25 2021-05-25 Dompe Farm Spa Formulazioni oftalmiche
WO2021123320A1 (en) * 2019-12-20 2021-06-24 Dr. Kalali Prof. Mostafazadeh Dipl. Ing. Miedl (Kmm) Gesellschaft Bürgerlichen Rechts A composition and its use for a universal therapy against tumor cells
AU2021251785A1 (en) * 2020-04-07 2022-11-03 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof
KR20230004709A (ko) 2020-04-22 2023-01-06 다이렉트 바이오로직스 엘엘씨 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
EP3970732A1 (en) * 2020-09-17 2022-03-23 Hunan Yuanpin Cell Technology Co. Ltd Use of mesenchymal stem cells in the treatment of viral infections and/or complications caused by viral infections
CN112656816A (zh) * 2021-01-15 2021-04-16 浙江大学 一种负载外泌体的纤维蛋白胶及其应用
US20220378846A1 (en) * 2021-06-01 2022-12-01 U-Neuron Biomedical Inc. Use of secretome of amniotic fluid stem cell in the treatment of dry eye disease
TWI864306B (zh) * 2021-07-07 2024-12-01 三鼎生物科技股份有限公司 間質幹細胞培養物及其製備方法
CN113583950A (zh) * 2021-08-06 2021-11-02 合肥滴碧云生物科技有限公司 一种制备干细胞活性因子的方法及其应用
CN114350603B (zh) * 2022-01-23 2022-08-23 上海揽微赛尔生物科技有限公司 包含外泌体的间充质干细胞胞外基质及其制备和在细胞修复中的应用
CN115282286B (zh) * 2022-02-09 2023-05-02 天津医科大学眼科医院 一种治疗眼部新生血管类疾病的纳米复合体及应用
KR20250044282A (ko) * 2022-07-08 2025-03-31 컴반지오, 인크. 분비체 활성 분석을 위한 방법 및 검정
CN120513095A (zh) * 2022-11-25 2025-08-19 希望细胞疗法株式会社 vMSC的分泌组及其用途
CN116473919A (zh) * 2023-03-13 2023-07-25 陕西初源外泌体生物科技有限公司 一种用于治疗视神经损伤的外泌体滴眼液及其制备方法
WO2024192119A1 (en) * 2023-03-14 2024-09-19 Direct Biologics, Llc Wound healing compositions and methods thereof
WO2025054528A2 (en) * 2023-09-06 2025-03-13 Theratom Bio, Inc. Modified stem cell secretome topical eye compositions and uses thereof
FR3153241A1 (fr) * 2023-09-22 2025-03-28 Med'inn'pharma Préparation pharmaceutique pro-résolutive sous forme de gel
US20250222035A1 (en) * 2024-01-10 2025-07-10 Combangio, Inc. Processes for making and using a mesenchyme stem cell secretome for limbal stem cell deficiency (lscd) treatment
WO2025226276A1 (en) 2024-04-25 2025-10-30 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
CN121102278A (zh) * 2025-11-17 2025-12-12 中国农业科学院特产研究所 含鹿茸干细胞分泌因子的滴眼液及其应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US20060165667A1 (en) 2004-12-03 2006-07-27 Case Western Reserve University Novel methods, compositions and devices for inducing neovascularization
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
JP2010500047A (ja) 2006-08-15 2010-01-07 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 間葉系幹細胞馴化培地
WO2008024996A2 (en) 2006-08-24 2008-02-28 Johnstone Brian H Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith
WO2009045359A1 (en) 2007-10-01 2009-04-09 Stemnion, Inc. Skin replacement compositions and methods
CN104623669A (zh) 2007-08-22 2015-05-20 斯丹姆涅恩有限公司 含细胞因子溶液的新组合物
PL2254586T3 (pl) 2008-02-22 2015-09-30 Agency For Science Tech And Research Astarstar Cząstki mezenchymalnych komórek macierzystych
US20110158958A1 (en) 2009-12-07 2011-06-30 Sing George L Methods for treating ophthalmic disorders, diseases and injuries
WO2010110768A1 (en) 2009-03-23 2010-09-30 Regenetech, Inc. Composition and method for producing composition for constructing tissue, and tissue construct
EP2251028A1 (en) * 2009-05-12 2010-11-17 Biocompatibles Uk Ltd. Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor
EP2451964B1 (en) 2009-07-10 2018-01-24 Histogen, Inc. Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
WO2011127090A1 (en) 2010-04-05 2011-10-13 Medstar Health Research Institute, Inc. Conditioned medium obtained form stem cells and its use in therapy
FR2974201B1 (fr) 2011-04-18 2013-04-12 Inside Secure Circuit de multiplication de montgomery
US20120276215A1 (en) 2011-04-26 2012-11-01 Riordan Neil H Therapeutic Conditioned Media
US9950016B2 (en) 2011-06-24 2018-04-24 National University Of Ireland, Galway Cell secreted proteins for the treatment of myocardial infarction
ITTO20111183A1 (it) 2011-12-21 2013-06-22 Univ Degli Studi Torino Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia
CN104204192A (zh) 2012-02-13 2014-12-10 加米达细胞有限公司 间充质干细胞调理的基质及其产生和使用方法
ITTO20120859A1 (it) 2012-10-02 2014-04-03 Univ Degli Studi Torino Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
CN103767985A (zh) * 2012-10-22 2014-05-07 吉林省霍普金斯药物研究院有限责任公司 人源血液或间充质干细胞分泌exosome的制备与应用
AU2014205557B2 (en) * 2013-01-09 2017-08-10 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US20140242043A1 (en) 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing or treating optic neuritis
US20140255355A1 (en) 2013-03-07 2014-09-11 Stemnion, Inc. Methods for treating blepharitis
CL2013003066A1 (es) * 2013-10-22 2014-07-25 Univ Chile Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
US9636364B2 (en) 2013-12-04 2017-05-02 Stemnion, Inc. Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
US9464272B2 (en) 2013-12-12 2016-10-11 Stemnion, Inc. Cell-derived composition
US20150335712A1 (en) 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
WO2016083500A1 (en) 2014-11-27 2016-06-02 Med Cell Europe Ag Secretomes and method for producing secretomes
WO2016082882A1 (en) 2014-11-27 2016-06-02 Med Cell Europe Ag Secretomes and method for producing secretomes
US20170080033A1 (en) 2014-12-16 2017-03-23 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
US20180327713A1 (en) 2014-12-16 2018-11-15 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
AU2015363088A1 (en) 2014-12-16 2017-06-15 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
KR101566450B1 (ko) 2015-04-03 2015-11-05 (유)스템메디케어 중간엽 줄기세포에서 단백질의 대량 생산 방법
TWI741980B (zh) * 2015-04-07 2021-10-11 大陸商四川藍光英諾生物科技股份有限公司 一種生物磚及其用途
US20160361253A1 (en) 2015-06-13 2016-12-15 Noveome Biotherapeutics, Inc. Novel Methods for Delivering Therapeutic Agents to the Eye via Nasal Passages
WO2017001649A1 (en) 2015-07-02 2017-01-05 Med Cell Europe Ag Secretomes and method for producing secretomes
US20180220642A1 (en) 2015-07-29 2018-08-09 Indiana University Research And Technology Corporation Materials and methods for treating and evaluating ischemic and/or reperfusion-injured tissue and/or tissue susceptible to same
US20190046576A1 (en) * 2016-02-12 2019-02-14 Cell Care Therapeutics Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same
KR20170111057A (ko) 2016-03-25 2017-10-12 (주)안트로젠 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
WO2017217967A1 (en) 2016-06-13 2017-12-21 Noveome Biotherapeutics, Inc. Novel methods for delivering therapeutic agents to the eye via nasal passages
US20180028570A1 (en) 2016-08-01 2018-02-01 Ucl Business Plc Angiogenic Factors
KR20180024223A (ko) * 2016-08-29 2018-03-08 사회복지법인 삼성생명공익재단 중간엽 줄기세포 분비 단백질을 포함하는 말초신경 세포 증식 촉진용 조성물
WO2018070939A1 (en) * 2016-10-12 2018-04-19 Agency For Science, Technology And Research Method for lyophilising an exosome
WO2018102174A1 (en) 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
EP3568141B1 (en) 2017-01-16 2020-12-16 Cells for Cells S.A. Composition comprising a substantially pure population of multipotent stromal cells encapsulated in platelet-poor plasma (ppp)
US20180271914A1 (en) 2017-03-21 2018-09-27 Noveome Biotherapeutics, Inc. Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury
WO2018213795A1 (en) 2017-05-18 2018-11-22 The Board Of Trustees Of The Leland Stanford Junior University Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue
WO2019016799A1 (en) 2017-07-16 2019-01-24 Ramot At Tel-Aviv University Ltd. SECRETEOME OF HUMAN MUCOSAL MUCOSAL STEM CELLS
US10364270B2 (en) 2017-10-02 2019-07-30 Pro Sunfun Biotech Research And Developmment Co., Ltd. Eye-care peptide, its composition and method of using the same
CN108517002A (zh) * 2018-04-20 2018-09-11 命之本源医疗科技（北京）有限公司 一种干细胞培养上清分泌蛋白的稳定剂
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome

Similar Documents

Publication Publication Date Title
US11129853B2 (en) Processes for making and using a mesenchymal stem cell derived secretome
US12186430B2 (en) Lyophilized mesenchymal stem cell derived secretome and uses thereof
JP2023521086A5 (enExample)
CA2581652C (en) Formulations and methods for treatment of inflammatory diseases
JP2024525479A5 (enExample)
JP2023134610A (ja) 椎間板治療用組成物
US20230002476A1 (en) Processes for making and using a cellular fibronectin composition
CN115105464A (zh) 一种纳米复合水凝胶及其制备方法和应用
KR20180008137A (ko) Il-8 및 골수농축액의 조합을 이용한 연골 재생
NZ781988B2 (en) Processes for making and using a mesenchymal stem cell derived secretome
US20250222035A1 (en) Processes for making and using a mesenchyme stem cell secretome for limbal stem cell deficiency (lscd) treatment
HK40072346A (en) Processes for making and using a mesenchymal stem cell derived secretome
HK40084071A (en) Lyophilized mesenchymal stem cell derived secretome and uses thereof
CN116919967B (zh) 亚叶酸钙在制备促角膜修复药物中的应用
Cheng et al. Mechanism of Transplanted Novel Umbilical Cord Mesenchymal Stem Cells with High Cytokine Secretion for the Treatment of Vaginitis
WO2026072817A1 (en) Treatment of idiopathic facial paralysis with extracellular vesicle composition
AU2023338294A1 (en) Preparation and purification methods for mesenchymal stem cell derived secretome